(Q40677846)

22 September 2017

1 reference

title

A risk-benefit assessment of teicoplanin in the treatment of infections (English)

1 reference

22 September 2017

F de Lalla

1

1 reference

22 September 2017

A Tramarin

series ordinal

2

1 reference

22 September 2017

publication date

1 November 1995

1 reference

22 September 2017

1 reference

22 September 2017

volume

13

1 reference

22 September 2017

issue

5

1 reference

22 September 2017

page(s)

317-328

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199513050-00005

22 September 2017

exact match

0 references

cites work

Spanish experience with teicoplanin

1 reference

12 December 2020

Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria

1 reference

12 December 2020

Safety and efficacy of teicoplanin for bone and joint infections: results of a community-based trial.

1 reference

12 December 2020

Comparison of intravenous teicoplanin with intramuscular amoxycillin for the prophylaxis of streptococcal bacteraemia in dental patients.

1 reference

12 December 2020

Comparison of efficacy and safety of teicoplanin in gram-positive infections: a multicentre study

1 reference

12 December 2020

Dosage recommendations for teicoplanin

1 reference

12 December 2020

Teicoplanin in home therapy of the terminally ill child.

1 reference

12 December 2020

Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Canc

1 reference

12 December 2020

Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity

1 reference

12 December 2020

4-week treatment of streptococcal native valve endocarditis with high-dose teicoplanin

1 reference

12 December 2020

The role of Gram-positive therapy in the neutropenic patient

1 reference

12 December 2020

Teicoplanin-induced ototoxicity in Down's syndrome.

1 reference

12 December 2020

A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer

1 reference

12 December 2020

Comparison of vancomycin- and teicoplanin-induced histamine release and "red man syndrome".

1 reference

12 December 2020

Teicoplanin--its role as systemic therapy of burn infections and as prophylaxis for orthopaedic surgery. Italian Study Groups for Antimicrobial Prophylaxis in Orthopaedic Surgery and Burns

1 reference

12 December 2020

Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.

1 reference

12 December 2020

Antibiotic prophylaxis in cardiac surgery: a prospective comparison of two dosage regimens of teicoplanin with a combination of flucloxacillin and tobramycin

1 reference

12 December 2020

Evaluation of intraventricular teicoplanin for the treatment of neurosurgical shunt infections

1 reference

12 December 2020

A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies

1 reference

12 December 2020

Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetration

1 reference

12 December 2020

Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts

1 reference

12 December 2020

Use of teicoplanin in community medicine

1 reference

12 December 2020

Teicoplanin monotherapy of serious infections caused by Gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trial

1 reference

12 December 2020

Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteremia in febrile granulocytopenic patients

1 reference

12 December 2020

Teicoplanin vs cephamandole for antimicrobial prophylaxis in prosthetic joint implant surgery: (preliminary results)

1 reference

12 December 2020

Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer

1 reference

12 December 2020

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

12 December 2020

Leukopenia with neutropenia associated with teicoplanin therapy

1 reference

12 December 2020

The use of a new glycopeptide antibiotic, teicoplanin, in the treatment of bacterial endocarditis

1 reference

12 December 2020

Regional and systemic prophylaxis with teicoplanin in monolateral and bilateral total knee replacement procedures: study of pharmacokinetics and tissue penetration

1 reference

12 December 2020

Teicoplanin nephrotoxicity: first case report.

1 reference

12 December 2020

Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program

1 reference

12 December 2020

Pharmacokinetics of teicoplanin upon multiple dose intravenous administration to normal healthy male volunteers

1 reference

12 December 2020

Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea

1 reference

12 December 2020

Intravenous or Intramuscular Teicoplanin Once Daily for Skin and Soft-Tissue Infections

1 reference

12 December 2020

Treatment of Clostridium difficile associated diarrhea and colitis with an oral preparation of teicoplanin; a dose finding study. The Swedish CDAD Study Group

1 reference

12 December 2020

Infections due to Gram-positive organisms in children: possible role for teicoplanin

1 reference

12 December 2020

Evaluation of New Anti-Infective Drugs for Surgical Prophylaxis

1 reference

12 December 2020

An Open Study of Teicoplanin in the Treatment of Gram-Positive Infections

1 reference

12 December 2020

Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients

1 reference

12 December 2020

Anaphylactoid reactions to glycopeptide antibiotics

1 reference

12 December 2020

In vitro activity and human pharmacokinetics of teicoplanin

1 reference

12 December 2020

The efficacy of teicoplanin in the treatment of endocarditis caused by gram-positive bacteria

1 reference

12 December 2020

A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria

1 reference

12 December 2020

Pharmacokinetics and Bioavailability of a New Formulation of Teicoplanin following Intravenous and Intramuscular Administration to Humans

1 reference

12 December 2020

Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin

1 reference

12 December 2020

Teicoplanin as modification of initial empirical therapy in febrile granulocytopenic patients

1 reference

12 December 2020

Ceftriaxone alone or in Combination with Teicoplanin in the Management of Febrile Episodes in Neutropenic Children and Adolescents with Cancer on an Outpatient Base

1 reference

12 December 2020

Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA

1 reference

12 December 2020

Teicoplanin--home therapy for prosthetic joint infections

1 reference

12 December 2020

Pharmacokinetics of 14C-teicoplanin in healthy volunteers

1 reference

12 December 2020

Clinical evaluation of teicoplanin in the treatment of gram-positive bacterial intravascular infections

1 reference

12 December 2020

Allergic cross-reaction of teicoplanin and vancomycin

1 reference

12 December 2020

Structure and mechanism of action of teicoplanin

1 reference

12 December 2020

A review of the safety profile of teicoplanin

1 reference

12 December 2020

IgE-mediated reaction to vancomycin and teicoplanin after treatment with vancomycin

1 reference

12 December 2020

A critical review of the dosage of teicoplanin in Europe and the USA.

1 reference

12 December 2020

Allergic cross-reactivity to teicoplanin and vancomycin

1 reference

12 December 2020

Red Man Syndrome with Teicoplanin

1 reference

12 December 2020

Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

12 December 2020

Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon

1 reference

12 December 2020

Pharmacokinetics and tolerability of teicoplanin in healthy volunteers after single increasing doses

1 reference

12 December 2020

10.2165/00002018-199513050-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

22 September 2017

1017566761

0 references

1 reference